Flamingo-01 Phase III GP2 Product Press Releases Email Alerts
Greenwich LifeSciences
  • ABOUT
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
  • TECHNOLOGY
    • OUR GLSI-100 CANCER IMMUNOTHERAPY PRODUCT
    • CANCER AND IMMUNOTHERAPY OVERVIEW
  • CLINICAL TRIALS
    • COMPLETED CLINICAL TRIALS
    • FLAMINGO-01 PHASE III CLINICAL TRIAL
  • INVESTORS & MEDIA
    • OVERVIEW
    • NEWS & EVENTS
    • COMPANY INFO
    • STOCK INFO
    • SEC FILINGS
    • GOVERNANCE
  • CONTACT
  • ABOUT
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
  • TECHNOLOGY
    • OUR GLSI-100 CANCER IMMUNOTHERAPY PRODUCT
    • CANCER AND IMMUNOTHERAPY OVERVIEW
  • CLINICAL TRIALS
    • COMPLETED CLINICAL TRIALS
    • FLAMINGO-01 PHASE III CLINICAL TRIAL
  • INVESTORS & MEDIA
    • OVERVIEW
    • NEWS & EVENTS
    • COMPANY INFO
    • STOCK INFO
    • SEC FILINGS
    • GOVERNANCE
  • CONTACT

Presentations

Nasdaq: GLSI

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Presentations
    • FAQ
  • Stock Info
  • SEC Filings
  • Governance
  • Company Info

  • Presentations
  • FAQ
Presentation at HCW Conference on September 14, 2026

Presentation at HCW Conference on September 14, 2026

Interview on Bloomberg TV on April 26, 2026

Interview on Bloomberg TV on April 26, 2026

Commentary by Noble Research Analyst on Protocol Amendment on July 21, 2026

Commentary by Noble Research Analyst on Protocol Amendment on July 21, 2026

Fireside Chat with Research Analyst at Noble Conference on June 3, 2026

Fireside Chat with Research Analyst at Noble Conference on June 3, 2026

Corporate Presentation - September 2026 (PDF)

Corporate Presentation - September 2026 (PDF)

RSS

By proceeding to use this website, you consent to our use of cookies as described in our Privacy Policy.

Email Alerts

Sign up Now

Sign me up for:

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.
  • Tear Sheet
  • RSS Feed
Logo of Greenwich LifeSciences.

Copyright © 2026

Greenwich LifeSciences, Inc.

ABOUT
TECHNOLOGY
CLINICAL TRIALS
INVESTORS & MEDIA
CONTACT
X logo
Privacy Policy
Disclaimer
Sitemap
Logo of Greenwich LifeSciences.

Copyright © 2026

Greenwich LifeSciences, Inc.

ABOUT
TECHNOLOGY
CLINICAL TRIALS
INVESTORS & MEDIA
CONTACT
Disclaimer
Privacy Policy
Sitemap
X logo